Zhijun Tan

Zhijun Tan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
HZHaiyue Zhang
Haiyue Zhang
XLXinrui Li
Xinrui Li
YWYuan Wang
Yuan Wang
WZWei Zhang
Wei Zhang
YLYing Liang
Ying Liang
LSLei Shang
Lei Shang
Background: There is currently no widely accepted multidimensional tool to assess adult dietary behaviors in China. This study developed the Chinese Adults Dietary Behavior Scale (CADBS) to evaluate Chinese adults’ eating-related traits and preliminarily examined its reliability, validity, and ability to distinguish different groups. Methods: The scale was developed through three rounds of surveys conducted from 2020 to 2021. Items were screened using item analysis. After item selection, exploratory and confirmatory factor analyses were used to determine the final structure of the scale, and its reliability, structural validity, and discriminative ability were assessed accordingly. Results: The final scale consisted of 7 dimensions with 39 items: snacking, food responsiveness, emotional eating, restrictive eating, food fussiness, healthy dietary awareness, and external eating. Exploratory factor analysis showed a total cumulative variance contribution rate of 60.60%. Confirmatory factor analysis yielded a Tucker–Lewis index (TLI) of 0.892 and a comparative fit index (CFI) of 0.903. The total scale had a Cronbach’s α coefficient of 0.890, a split-half reliability coefficient of 0.920, and a test–retest reliability coefficient of 0.740. Snacking ( β = 0.422), food responsiveness ( β = 0.412), and restrictive eating ( β = 0.675) were positively associated with BMI, while healthy dietary awareness ( β = −0.396) was negatively associated with BMI. Conclusion: Following standard procedures, this study developed a self-report scale for assessing Chinese adults’ dietary behaviors. The CADBS has good reliability and structural validity, making it suitable for epidemiological surveys of dietary behaviors and public health intervention practices. Specifically, it shows that Chinese adults who snack more have stronger food responsiveness and are more likely to be overweight or obese. Conversely, an overweight or obese Chinese adult tends to be restrictive about eating. On the contrary, those with greater healthy dietary awareness are more likely to have a normal weight.

2 June 2026 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
CGChengcheng Gao
Chengcheng Gao
HZHaiyue Zhang
Haiyue Zhang
RZRui Zhang
Rui Zhang
NLNan Li
Nan Li
YSYanfang Song
Yanfang Song
LSLei Shang
Lei Shang
Background: The pathological heterogeneity of sepsis makes it challenging for traditional scoring systems to balance early-warning sensitivity, dynamic progression characterization, and mechanistic interpretability. Developing a multi-objective optimization algorithm incorporating rheological properties to screen novel composite parameters from routine indicators, thereby constructing a precise sepsis assessment tool with both clinical feasibility and pathological interpretability, offers a new approach to inform clinical decisions and prognosis prediction for sepsis patients. This retrospective prognostic model development and validation study aimed to develop and externally validate novel composite indices for sepsis mortality prediction. Methods: Using data from the eICU (derivation cohort, n = 3,965) and MIMIC-IV (temporal validation cohort, n = 2,917) databases, we developed the Multi-Objective Non-Newtonian Fluid Optimization (MONNF) algorithm through physically inspired dynamic viscoelastic regulation, multi-target synergistic constraints, and medical knowledge-embedding strategies integrated with key pathological dimensions of sepsis. This algorithm screened novel indicators capturing the pathophysiological interplay among circulatory compromise, coagulopathy, and metabolic derangement. Subsequently, an Under-sampling Synchronous Evolutionary Ensemble (USEE) prediction model was established to validate its cross-center generalizability and clinical utility. Results: The initial phase of MONNF identified the Hypoxia-Coagulation-Hemoglobin Index (HCH; components: lactate, INR, hemoglobin) with a 28-day mortality ROC-AUC of 0.67, superior to SOFA (ROC-AUC = 0.63). The later phase constructed the Hepatic-Pulmonary-Metabolic Synergistic Index (HPMS; components: total bilirubin, PaO₂/FiO₂, bicarbonate, albumin) with a ROC-AUC of 0.64. Risk inflection points of the new indicators revealed critical intervention windows (pnonlinear < 0.001), while Boruta feature importance ranking confirmed their higher decision weight than traditional variables. The USEE model demonstrated optimal predictive performance in independent validation (ROC-AUC = 0.84, PR-AUC = 0.71). Conclusion: In this retrospective development and validation study, a novel optimization algorithm based on dynamic non-Newtonian fluid properties successfully uncovered composite indicators that profoundly characterize core pathological features of sepsis. This work provides an innovative solution to simplify clinical stratification and address the tripartite paradox in prognostic assessment: efficiency versus sensitivity versus interpretability.

27 April 2026 in Military Medical Research
Verified
Journal Article
Open access
ZLZi-Chao Li
Zi-Chao Li
YZYi-Fu Zhu
Yi-Fu Zhu
YSYa-Juan Song
Ya-Juan Song
ZTZhijun Tan
Zhijun Tan
BLBin Liu
Bin Liu
WLWei Liu
Wei Liu
Abnormal glucose metabolism often contributes to myofibroblast activation and the pathogenesis of skin fibrotic diseases. All-trans retinoic acid (ATRA), the active component of tretinoin cream, can regulate glucose metabolism and activate myofibroblasts. Importantly, investigating the potential of ATRA to inhibit myofibroblast activation by modulating glucose metabolism could reveal the translational significance of ATRA in attenuating hypertrophic scar (HS) formation. We first conducted a multicenter, double-blind, randomized controlled trial (RCT) to compare the effects of tretinoin cream with those of the first-line medication, silicone gel. In the mechanistic study, the characteristics of glucose metabolic reprogramming and the activation of hypertrophic scar fibroblasts (HSFs) after ATRA treatment were identified through multi-omics profiling, complemented by glucose metabolism assays and functional validations. Besides, genetic overexpression targeting the potential downstream molecules of ATRA, including hypermethylated in cancer 1 (HIC1), phosphoenolpyruvate carboxykinase (PCK)1, and PCK2, was conducted in vitro in HSFs and in vivo in skin fibroblasts of Col1a2-CreER mice. Our RCT demonstrated that tretinoin cream is non-inferior to silicone gel in preventing HS formation, with the absolute risk difference of incidence rates [–8.65% 90% two-sided confidence interval (CI) –23.03 to 5.74] and in decreasing scar thickness [(2856.20±211.83) μm vs. (1664.57±273.50) μm], attributing to the reduction in HSF proliferation and the proportion of myofibroblasts. Moreover, tretinoin cream effectively mitigated HS formation in both mice and rabbits without impeding normal wound healing. Mechanistically, HSFs underwent glucose reprogramming, characterized by increased aerobic glycolysis, which facilitated the transition of HSFs to myofibroblasts and their proliferation. However, ATRA upregulated HIC1, PCK1, and PCK2 expression through retinoic acid receptor alpha (RARα) activation, thereby inhibiting the fibrotic phenotypes of HSFs by suppressing aerobic glycolysis and facilitating gluconeogenesis. The fibroblast-specific overexpression of HIC1, PCK1, or PCK2 in Col1a2-CreER mice significantly reduced myofibroblast activation and hypertrophic scarring. Our study not only substantiated that topical tretinoin cream could serve as an effective strategy to prevent HSs in clinical settings, but also established ATRA as a regulator of glucose metabolism. Importantly, ATRA/RARα-mediated glucose reprogramming was identified as a potential therapeutic target for attenuating HS formation. ChiCTR, ChiCTR2500097242. Registered on 14 Feb, 2025. Available from https://www.chictr.org.cn/bin/project/edit?pid=220146.